These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 15320480)

  • 21. Cardiovascular biology of the asymmetric dimethylarginine:dimethylarginine dimethylaminohydrolase pathway.
    Vallance P; Leiper J
    Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1023-30. PubMed ID: 15105281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid NOS-1-derived nitric oxide and peroxynitrite formation act as signaling agents for inducible NOS-2 expression in vascular smooth muscle cells.
    Scheschowitsch K; de Moraes JA; Sordi R; Barja-Fidalgo C; Assreuy J
    Pharmacol Res; 2015 Oct; 100():73-84. PubMed ID: 26253183
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inducible nitric oxide synthase pathway in the central nervous system and vasopressin release during experimental septic shock.
    Giusti-Paiva A; De Castro M; Antunes-Rodrigues J; Carnio EC
    Crit Care Med; 2002 Jun; 30(6):1306-10. PubMed ID: 12072686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nitric oxide in sepsis-syndrome: potential treatment of septic shock by nitric oxide synthase antagonists.
    Ketteler M; Cetto C; Kirdorf M; Jeschke GS; Schäfer JH; Distler A
    Kidney Int Suppl; 1998 Feb; 64():S27-30. PubMed ID: 9475485
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nitric oxide in cardiovascular disorders.
    Dusting GJ
    J Vasc Res; 1995; 32(3):143-61. PubMed ID: 7772676
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathophysiological relevance of NO signaling in the cardiovascular system: novel insight from mice lacking all NO synthases.
    Tsutsui M; Shimokawa H; Otsuji Y; Yanagihara N
    Pharmacol Ther; 2010 Dec; 128(3):499-508. PubMed ID: 20826180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nitric oxide availability in diabetes mellitus.
    Honing ML; Morrison PJ; Banga JD; Stroes ES; Rabelink TJ
    Diabetes Metab Rev; 1998 Sep; 14(3):241-9. PubMed ID: 9816472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nitric oxide, a janus-faced therapeutic target for diabetic microangiopathy-Friend or foe?
    Yamagishi S; Matsui T
    Pharmacol Res; 2011 Sep; 64(3):187-94. PubMed ID: 21635951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The L-arginine: nitric oxide pathway.
    Palmer RM
    Curr Opin Nephrol Hypertens; 1993 Jan; 2(1):122-8. PubMed ID: 7522910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nitric oxide-dependent endothelial function and cardiovascular disease.
    Desjardins F; Balligand JL
    Acta Clin Belg; 2006; 61(6):326-34. PubMed ID: 17323842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered L-arginine/nitric oxide synthase/nitric oxide pathway in the vascular adventitia of rats with sepsis.
    Jia YX; Pan CS; Yang JH; Liu XH; Yuan WJ; Zhao J; Tang CS; Qi YF
    Clin Exp Pharmacol Physiol; 2006 Dec; 33(12):1202-8. PubMed ID: 17184502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inducible nitric oxide synthase in the cardiovascular system.
    Bhagat K; Vallance P
    Heart; 1996 Mar; 75(3):218-20. PubMed ID: 8800980
    [No Abstract]   [Full Text] [Related]  

  • 33. Hormonal Regulation of Nitric Oxide (NO) in Cardio-metabolic Diseases.
    Sudar-Milovanovic E; Zafirovic S; Jovanovic A; Trebaljevac J; Obradovic M; Cenic-Milosevic D; Isenovic ER
    Curr Pharm Des; 2017; 23(10):1427-1434. PubMed ID: 28120715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The tragedy of TRIUMPH for nitric oxide synthesis inhibition in cardiogenic shock: where do we go from here?
    Bailey A; Pope TW; Moore SA; Campbell CL
    Am J Cardiovasc Drugs; 2007; 7(5):337-45. PubMed ID: 17953472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes.
    Bitar MS; Wahid S; Mustafa S; Al-Saleh E; Dhaunsi GS; Al-Mulla F
    Eur J Pharmacol; 2005 Mar; 511(1):53-64. PubMed ID: 15777779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Upregulation of renal and vascular nitric oxide synthase in young spontaneously hypertensive rats.
    Vaziri ND; Ni Z; Oveisi F
    Hypertension; 1998 Jun; 31(6):1248-54. PubMed ID: 9622137
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The red blood cell: a new key player in cardiovascular homoeostasis? Focus on the nitric oxide pathway.
    Porro B; Eligini S; Squellerio I; Tremoli E; Cavalca V
    Biochem Soc Trans; 2014 Aug; 42(4):996-1000. PubMed ID: 25109992
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin resistance: potential role of the endogenous nitric oxide synthase inhibitor ADMA.
    Sydow K; Mondon CE; Cooke JP
    Vasc Med; 2005 Jul; 10 Suppl 1():S35-43. PubMed ID: 16444867
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mitochondrial nitric oxide synthase participates in septic shock myocardial depression by nitric oxide overproduction and mitochondrial permeability transition pore opening.
    Xu C; Yi C; Wang H; Bruce IC; Xia Q
    Shock; 2012 Jan; 37(1):110-5. PubMed ID: 21993446
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nitric oxide.
    Moncada S
    J Hypertens Suppl; 1994 Dec; 12(10):S35-9. PubMed ID: 7539493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.